Heat treatment of the prostate: Where do we stand in 2000?

Current Opinion in Urology

Volumn 11, Issue 1, 2001, Pages 35-41

  Floratos, Diamandis L ^a   De La Rosette, Jean J M C H ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT;

CLINICAL RESEARCH; CLINICAL TRIAL; HUMAN; HYPERTHERMIC THERAPY; MALE; MORBIDITY; PATIENT MONITORING; PRIORITY JOURNAL; PROSTATE HYPERTROPHY; REVIEW; TISSUE BLOOD FLOW; TRANSURETHRAL MICROWAVE THERMOTHERAPY; TRANSURETHRAL RESECTION; TREATMENT INDICATION; TREATMENT OUTCOME; URETHRA DISEASE;

HUMANS; HYPERTHERMIA, INDUCED; MALE; PROSTATIC HYPERPLASIA; RESEARCH; URINATION DISORDERS;

EID: 0035149727     PISSN: 09630643     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042307-200101000-00005     Document Type: Review

References (47)

1. Transurethral prostatectomy: Immediate and postoperative complications. A cooperative study of 13 participating institutions evaluating 3,885 patients
2. Transurethral prostatectomy: Mortality and morbidity
3. Immediate and postoperative complications of transurethral prostatectomy in the 1990s
4. Current status of thermotherapy of the prostate
5. Transurethral needle ablation of the prostate for treatment of benign prostatic hyperplasia: Early clinical experience
6. Thermal ablation of BPH with transrectal high-intensity focused ultrasound
7. Lasers in the treatment of benign prostatic obstruction: Past, present, and future
8. History of non-surgical treatment
9. Transrectal and transurethral hyperthermia versus sham treatment in benign prostatic hyperplasia: A double-blind randomized multicentre clinical trial
10. Long-term results of lower energy transurethral microwave thermotherapy
11. Three-year follow-up after transurethral microwave thermotherapy (TUMT) for benign prostatic hyperplasia using the PRIMUS U+R device
12. Prospective randomized comparison of high energy transurethral microwave thermotherapy versus alpha-blocker treatment of patients with benign prostatic hyperplasia
13. Transurethral thermotherapy for benign prostatic hyperplasia significantly decreases infravesical obstruction: Results in 134 patients after 1 year
14. Temperature controlled high energy transurethral microwave thermotherapy for benign prostatic hyperplasia using a heat shock strategy
15. Clinical efficacy of a new 30-minutes algorithm for transurethral microwave thermotherapy (TUMT 3.5): Initial results
16. Mechanism of microwave thermotherapy
17. High energy thermotherapy in the treatment of benign prostatic hyperplasia: Results of the European Benign Prostatic Hyperplasia Study Group
18. Radioligand-binding analysis of human prostatic alpha-1 adrenoreceptor density following transurethral microwave therapy
19. Denervation of periurethral prostatic tissue by transurethral microwave thermotherapy
20. Effect of heat exposure on viability and contractility of cultured prostatic stromal cells
21. Morphological changes in prostatic adenomas after transurethral microwave thermotherapy
22. Heat-induced apoptosis in human prostatic stromal cells
23. Comparison of therapies for lower urinary tract symptoms
24. Transurethral microwave thermotherapy
25. New technologies for the surgical management of symptomatic benign prostatic enlargement: Tolerability and morbidity of high energy transurethral microwave thermotherapy
26. High-energy transurethral microwave thermotherapy (TUMT 2.5) in the treatment of BPH. Results of a prospective study with 4-years follow-up
27. Tolerability of 3.5 versus 2.5 high-energy transurethral microwave thermotherapy
28. A novel intraurethral prostatic bridge catheter for prevention of temporary prostatic obstruction following high energy transurethral microwave thermotherapy in patients with benign prostatic hyperplasia
29. Neoadjuvant and adjuvant alphablockade improves early results of high-energy transurethral microwave thermotherapy for lower urinary tract symptoms of benign prostatic hyperplasia: A randomized, prospective clinical trial
30. Temporary intraurethral prostatic bridge-catheter compared with neoadjuvant and adjuvant alpha-blockade to improve early results of high-energy transurethral microwave thermotherapy
31. Does old age contraindicate TURP?
32. Results of high-energy transurethral microwave thermotherapy in patients categorized according to the American Society of Anesthesiologists operative risk classification
33. High-energy transurethral microwave thermotherapy in patients with acute urinary retention due to benign prostatic hyperplasia
34. High energy transurethral microwave thermotherapy for the treatment of patients in urinary retention
35. Long-term outcome of transurethral high-intensity focused ultrasound therapy for benign prostatic hyperplasia
36. How to select patients for high-energy transurethral microwave thermotherapy
37. Pretreatment prostate-specific antigen as an outcome predictor of targeted transurethral microwave thermotherapy
38. Transurethral microwave thermotherapy for benign prostatic hyperplasia: Relation between clinical response and prostate histology
39. Can histopathology predict treatment outcome following high-energy transurethral microwave thermotherapy of the prostate? Results of a biopsy study
40. Optimizing transurethral microwave thermotherapy: A model for studying power, blood flow, temperature variations and tissue destruction
41. Thermoregulation in the canine prostate during transurethral microwave hyperthermia, part II: Blood flow response
42. Increased prostatic blood flow in response to microwave thermal treatment: Preliminary findings in two patients with benign prostatic hyperplasia
43. Contrast angiosonography: A technology to improve Doppler ultrasound examinations of the prostate
44. Intraprostatic temperature monitoring during transurethral microwave thermotherapy: Status and future developments